Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus. (Record no. 28302962)

MARC details
000 -LEADER
fixed length control field 01724 a2200493 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517212244.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201907s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2326-5205
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/art.40511
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Doria, A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190722
245 00 - TITLE STATEMENT
Title Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Arthritis & rheumatology (Hoboken, N.J.)
Date of publication, distribution, etc. 08 2018
300 ## - PHYSICAL DESCRIPTION
Extent 1256-1264 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Antinuclear
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Complement C3
General subdivision deficiency
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element DNA
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Injections, Subcutaneous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Intention to Treat Analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lupus Erythematosus, Systemic
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Severity of Illness Index
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stohl, W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schwarting, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Okada, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Scheinberg, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name van Vollenhoven, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hammer, A E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Groark, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bass, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fox, N L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roth, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gordon, D
773 0# - HOST ITEM ENTRY
Title Arthritis & rheumatology (Hoboken, N.J.)
Related parts vol. 70
-- no. 8
-- p. 1256-1264
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/art.40511">https://doi.org/10.1002/art.40511</a>
Public note Available from publisher's website

No items available.